Prophylaxis, Preemption and Drug Resistance in CMV Infection: Too Little, Too Much or Just Right?
Article first published online: 22 SEP 2011
©Copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 12, Issue 1, pages 13–14, January 2012
How to Cite
Fishman, J. A. (2012), Prophylaxis, Preemption and Drug Resistance in CMV Infection: Too Little, Too Much or Just Right?. American Journal of Transplantation, 12: 13–14. doi: 10.1111/j.1600-6143.2011.03764.x
- Issue published online: 13 JAN 2012
- Article first published online: 22 SEP 2011
- Received 25 July 2011, revised 9 August 2011 and accepted for publication 16 August 2011
For cytomegalovirus, since the emergence of resistance to antiviral agents is associated with the host's immune status and the level of viral replication during exposure to antiviral therapy, the rate of viral resistance with induction and other newer immunosuppressive regimens merits investigation. See article by Couzi et al on page 202.